165 related articles for article (PubMed ID: 17339454)
1. Differential regulation of human NK cell-mediated cytotoxicity by the tyrosine kinase Itk.
Khurana D; Arneson LN; Schoon RA; Dick CJ; Leibson PJ
J Immunol; 2007 Mar; 178(6):3575-82. PubMed ID: 17339454
[TBL] [Abstract][Full Text] [Related]
2. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
Doubrovina ES; Doubrovin MM; Vider E; Sisson RB; O'Reilly RJ; Dupont B; Vyas YM
J Immunol; 2003 Dec; 171(12):6891-9. PubMed ID: 14662896
[TBL] [Abstract][Full Text] [Related]
3. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.
Sutherland CL; Chalupny NJ; Schooley K; VandenBos T; Kubin M; Cosman D
J Immunol; 2002 Jan; 168(2):671-9. PubMed ID: 11777960
[TBL] [Abstract][Full Text] [Related]
4. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
[TBL] [Abstract][Full Text] [Related]
5. NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway.
Billadeau DD; Upshaw JL; Schoon RA; Dick CJ; Leibson PJ
Nat Immunol; 2003 Jun; 4(6):557-64. PubMed ID: 12740575
[TBL] [Abstract][Full Text] [Related]
6. Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
Trotta R; Puorro KA; Paroli M; Azzoni L; Abebe B; Eisenlohr LC; Perussia B
J Immunol; 1998 Dec; 161(12):6648-56. PubMed ID: 9862693
[TBL] [Abstract][Full Text] [Related]
7. The isoforms of phospholipase C-gamma are differentially used by distinct human NK activating receptors.
Upshaw JL; Schoon RA; Dick CJ; Billadeau DD; Leibson PJ
J Immunol; 2005 Jul; 175(1):213-8. PubMed ID: 15972651
[TBL] [Abstract][Full Text] [Related]
8. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
9. Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity.
Bonnema JD; Karnitz LM; Schoon RA; Abraham RT; Leibson PJ
J Exp Med; 1994 Oct; 180(4):1427-35. PubMed ID: 7931075
[TBL] [Abstract][Full Text] [Related]
10. Differential roles of Lck and Itk in T cell response to antigen recognition revealed by calcium imaging and electron microscopy.
Donnadieu E; Lang V; Bismuth G; Ellmeier W; Acuto O; Michel F; Trautmann A
J Immunol; 2001 May; 166(9):5540-9. PubMed ID: 11313393
[TBL] [Abstract][Full Text] [Related]
11. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
12. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE
J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177
[TBL] [Abstract][Full Text] [Related]
13. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases.
Zompi S; Hamerman JA; Ogasawara K; Schweighoffer E; Tybulewicz VL; Di Santo JP; Lanier LL; Colucci F
Nat Immunol; 2003 Jun; 4(6):565-72. PubMed ID: 12740576
[TBL] [Abstract][Full Text] [Related]
14. Specific subdomains of Vav differentially affect T cell and NK cell activation.
Billadeau DD; Mackie SM; Schoon RA; Leibson PJ
J Immunol; 2000 Apr; 164(8):3971-81. PubMed ID: 10754287
[TBL] [Abstract][Full Text] [Related]
15. Human tumor-derived exosomes down-modulate NKG2D expression.
Clayton A; Mitchell JP; Court J; Linnane S; Mason MD; Tabi Z
J Immunol; 2008 Jun; 180(11):7249-58. PubMed ID: 18490724
[TBL] [Abstract][Full Text] [Related]
16. Syk regulation of phosphoinositide 3-kinase-dependent NK cell function.
Jiang K; Zhong B; Gilvary DL; Corliss BC; Vivier E; Hong-Geller E; Wei S; Djeu JY
J Immunol; 2002 Apr; 168(7):3155-64. PubMed ID: 11907067
[TBL] [Abstract][Full Text] [Related]
17. DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapy.
Töpfer K; Cartellieri M; Michen S; Wiedemuth R; Müller N; Lindemann D; Bachmann M; Füssel M; Schackert G; Temme A
J Immunol; 2015 Apr; 194(7):3201-12. PubMed ID: 25740942
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell signaling pathways.
Vivier E; Nunès JA; Vély F
Science; 2004 Nov; 306(5701):1517-9. PubMed ID: 15567854
[TBL] [Abstract][Full Text] [Related]
19. Bcl10 plays a divergent role in NK cell-mediated cytotoxicity and cytokine generation.
Malarkannan S; Regunathan J; Chu H; Kutlesa S; Chen Y; Zeng H; Wen R; Wang D
J Immunol; 2007 Sep; 179(6):3752-62. PubMed ID: 17785812
[TBL] [Abstract][Full Text] [Related]
20. Human NK cytotoxicity against porcine cells is triggered by NKp44 and NKG2D.
Forte P; Lilienfeld BG; Baumann BC; Seebach JD
J Immunol; 2005 Oct; 175(8):5463-70. PubMed ID: 16210654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
